Lymphocyte counts help doctors diagnose, stage, and treat chronic lymphocytic leukemia (CLL). Other factors, such as the risk level of the type of CLL you have, also play a role. CLL is a slowly ...
The US Food and Drug Administration has approved revumenib (Revuforj — Syndax Pharmaceuticals) for relapsed or refractory acute leukemia with a KMT2A gene translocation in adult and pediatric ...
Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from the likes of Bristol Myers Squibb. The biotech had been enrolling ...